Efficacy of fludarabine, mitoxantrone, dexamethasone alternating with cyclophosphamide, doxorubicin, vincristine and prednisone (FMD/CHOP) in bulky follicular non-Hodgkin's lymphoma

被引：0
|
作者：
Wilder, DD
Ogden, JL
Jain, VK
机构：
[1] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[2] Texas Oncol PA, Dallas, TX USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2529
引用
收藏
页码：603A / 603A
页数：1
相关论文
共 50 条
  • [41] Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma
    Muringampurath-John, Disni
    Flowers, Christopher R.
    Toscano, Michael
    Chen Zhengjia
    Kaufman, Jonathan L.
    Arellano, Martha
    Bernal-Mizrachi, Leon
    Heffner, Leonard T.
    Lechowicz, Mary-Jo
    McLemore, Morgan
    Winton, Elliott
    Jaye, David L.
    Lonial, Sagar
    Khoury, Hanna Jean
    LEUKEMIA & LYMPHOMA, 2012, 53 (04) : 725 - 727
  • [42] Fludarabine-Mitoxantrone Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients
    Zinzani, Pier Luigi
    Pellegrini, Cinzia
    Broccoli, Alessandro
    Gandolfi, Letizia
    Stefoni, Vittorio
    Casadei, Beatrice
    Maglie, Roberto
    Argnani, Lisa
    Pileri, Stefano
    HEMATOLOGICAL ONCOLOGY, 2015, 33 (03) : 141 - 146
  • [43] MabThera (Rituximab) plus cyclophosphamide, vincristine and prednisone (CVP) chemotherapy improves survival in previously untreated patients with advanced follicular non-Hodgkin's lymphoma (NHL).
    Marcus, Robert E.
    Solal-Celigny, Philippe
    Imrie, Kevin
    Catalano, John V.
    Dmoszynska, Anna
    Raposo, Joao C.
    Offner, Fritz C.
    Gomez-Codina, Jose
    BLOOD, 2006, 108 (11) : 146A - 146A
  • [44] Obinutuzumab (GA101) in combination with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) or bendamustine for the first-line treatment of follicular non-Hodgkin lymphoma: final results from the maintenance phase of the phase Ib GAUDI study
    Dyer, M. J. S.
    Grigg, A.
    Diaz, M. Gonzalez
    Dreyling, M.
    Rule, S.
    Lei, G.
    Wassner-Fritsch, E.
    Knapp, A.
    Marlton, P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 53 - 53
  • [45] Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK®) after progression during rituximab, CHOP and fludarabine therapy
    Paschal, BR
    LEUKEMIA & LYMPHOMA, 2003, 44 (04) : 731 - 733
  • [46] Obinutuzumab (GA101) in Combination with CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) or Bendamustine for the First-Line Treatment of Follicular Non-Hodgkin Lymphoma: Final Results from the Maintenance Phase of the Phase Ib GAUDI Study
    Dyer, Martin J. S.
    Grigg, Andrew P.
    Gonzalez Diaz, Marcos
    Dreyling, Martin
    Rule, Simon
    Lei, Guiyuan
    Wassner-Fritsch, Elisabeth
    Fingerle-Rowson, Geunter
    Marlton, Paula V.
    BLOOD, 2014, 124 (21)
  • [47] Phase II study of cyclophosphamide, prednisone, and etoposide (CEOP-E) lymphoma epirubicin, vincristine, for aggressive non-Hodgkin's
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Park, TI
    Lee, KB
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (06) : 820 - 825
  • [48] A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma
    Tulpule, A
    Khan, AU
    Mohrbacher, AF
    Espina, BM
    Buchanan, L
    Berman, N
    Gorospe, G
    Boswell, WD
    Nathwani, BN
    Levine, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 604S - 604S
  • [49] Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma
    Visani, G
    Guiducci, B
    D'Adamo, F
    Mele, A
    Nicolini, G
    Leopardi, G
    Sparaventi, G
    Barulli, S
    Malerba, L
    Isidori, A
    Malagola, M
    Piccaluga, PP
    LEUKEMIA & LYMPHOMA, 2005, 46 (03) : 477 - 479
  • [50] Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP)
    Strati, Paolo
    Romaguera, Jorge E.
    Kwak, Larry W.
    Hagemeister, Fredrick B.
    Rodriguez, Alma
    Oki, Yasuhiro
    Westin, Jason
    Turturro, Francesco
    Overman, Michael J.
    Neelapu, Sattva S.
    Fowler, Nathan
    Fayad, Luis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S145 - S146
12345